Janet Roddy

2.8k total citations
52 papers, 1.5k citations indexed

About

Janet Roddy is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Janet Roddy has authored 52 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pathology and Forensic Medicine, 27 papers in Pulmonary and Respiratory Medicine and 10 papers in Epidemiology. Recurrent topics in Janet Roddy's work include Systemic Sclerosis and Related Diseases (42 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers) and Pulmonary Hypertension Research and Treatments (13 papers). Janet Roddy is often cited by papers focused on Systemic Sclerosis and Related Diseases (42 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers) and Pulmonary Hypertension Research and Treatments (13 papers). Janet Roddy collaborates with scholars based in Australia, United Kingdom and United States. Janet Roddy's co-authors include Susanna Proudman, Wendy Stevens, Mandana Nikpour, Joanne Sahhar, John Yudkin, Jane Zochling, Peter Nash, Eli Gabbay, Peter Youssef and Vivek Thakkar and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and The American Journal of Medicine.

In The Last Decade

Janet Roddy

52 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janet Roddy Australia 23 1.1k 755 369 268 232 52 1.5k
Nascimento Costa Portugal 15 218 0.2× 164 0.2× 138 0.4× 167 0.6× 84 0.4× 49 981
Senji Kasahara Japan 21 425 0.4× 161 0.2× 218 0.6× 260 1.0× 43 0.2× 85 1.3k
Alessandro Tomelleri Italy 21 116 0.1× 547 0.7× 101 0.3× 185 0.7× 43 0.2× 84 1.4k
Anand Devaraj United Kingdom 9 411 0.4× 1.5k 2.0× 282 0.8× 57 0.2× 24 0.1× 18 1.7k
Roland du Bois United Kingdom 13 214 0.2× 1.0k 1.4× 269 0.7× 73 0.3× 23 0.1× 23 1.3k
Paola Confalonieri Italy 16 141 0.1× 621 0.8× 103 0.3× 87 0.3× 41 0.2× 59 977
Jean‐François Augusto France 21 102 0.1× 375 0.5× 92 0.2× 469 1.8× 34 0.1× 86 1.3k
Elena Ossi Italy 17 120 0.1× 363 0.5× 164 0.4× 142 0.5× 28 0.1× 52 1.0k
Nuntana Kasitanon Thailand 21 227 0.2× 85 0.1× 181 0.5× 431 1.6× 41 0.2× 72 1.3k
Shuzo Yoshida Japan 15 74 0.1× 208 0.3× 271 0.7× 167 0.6× 51 0.2× 40 810

Countries citing papers authored by Janet Roddy

Since Specialization
Citations

This map shows the geographic impact of Janet Roddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Roddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Roddy more than expected).

Fields of papers citing papers by Janet Roddy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet Roddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Roddy. The network helps show where Janet Roddy may publish in the future.

Co-authorship network of co-authors of Janet Roddy

This figure shows the co-authorship network connecting the top 25 collaborators of Janet Roddy. A scholar is included among the top collaborators of Janet Roddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet Roddy. Janet Roddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hanson, Aimee, Joanne Sahhar, Gene‐Siew Ngian, et al.. (2022). Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes. Frontiers in Genetics. 13. 913196–913196. 9 indexed citations
2.
Roddy, Janet, et al.. (2021). Long-term Clinical Outcomes in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome. SHILAP Revista de lepidopterología. 5(3). 574–582. 7 indexed citations
3.
Ross, Laura, Wendy Stevens, Michelle Wilson, et al.. (2019). Can Patient‐Reported Symptoms Be Used to Measure Disease Activity in Systemic Sclerosis?. Arthritis Care & Research. 72(10). 1459–1465. 12 indexed citations
4.
Huq, Molla, Susanna Proudman, Joanne Sahhar, et al.. (2019). Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis. Arthritis Research & Therapy. 21(1). 57–57. 21 indexed citations
5.
Morrisroe, Kathleen, Wendy Stevens, Joanne Sahhar, et al.. (2019). The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia. BMC Pulmonary Medicine. 19(1). 226–226. 6 indexed citations
6.
Thakkar, Vivek, Karen A. Patterson, Wendy Stevens, et al.. (2018). Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestations. Clinical Rheumatology. 37(6). 1563–1571. 13 indexed citations
7.
Thakkar, Vivek, Wendy Stevens, David L. Prior, et al.. (2017). The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.. PubMed. 34 Suppl 100(5). 129–136. 16 indexed citations
8.
Owen, Claire, Gene‐Siew Ngian, O. Moore, et al.. (2017). Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.. PubMed. 34 Suppl 100(5). 170–176. 28 indexed citations
9.
Morrisroe, Kathleen, Wendy Stevens, Joanne Sahhar, et al.. (2017). Work productivity in systemic sclerosis, its economic burden and association with health-related quality of life. Lara D. Veeken. 57(1). 73–83. 22 indexed citations
10.
Morrisroe, Kathleen, Wendy Stevens, Molla Huq, et al.. (2017). Validity of the Workers Productivity and Activity Impairment Questionnaire: Specific Health Problem (WPAI:SHP) in patients with systemic sclerosis.. PubMed. 35 Suppl 106(4). 130–137. 22 indexed citations
11.
Hao, Yanjie, Vivek Thakkar, Wendy Stevens, et al.. (2015). A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis Research & Therapy. 17(1). 7–7. 88 indexed citations
12.
Hao, Yue, Wendy Stevens, Kathleen Morrisroe, et al.. (2014). A comparison of the predictive accuracy of three screening models (DETECT v.ESC/ERS v. ASIG) for pulmonary arterial hypertension in systemic sclerosis. Internal Medicine Journal. 44(11). 23–23. 1 indexed citations
13.
Thakkar, Vivek, Wendy Stevens, David L. Prior, et al.. (2013). Asymmetric dimethylarginine levels in the early detection of systemic sclerosis-related pulmonary arterial hypertension. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 1 indexed citations
14.
Stevens, Wendy, Vivek Thakkar, O. Moore, et al.. (2012). LUNG DISEASE IS THE MAJOR CAUSE OF DEATH IN THE AUSTRALIAN SSc COHORT STUDY. Lara D. Veeken. 51. 2 indexed citations
15.
Thakkar, Vivek, Wendy Stevens, David L. Prior, et al.. (2012). N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Research & Therapy. 14(3). R143–R143. 91 indexed citations
16.
Ngian, Gene‐Siew, Wendy Stevens, Janet Roddy, et al.. (2011). Survival and Predictors of Mortality In Australian Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension. Arthritis & Rheumatism. 63(10). 1 indexed citations
17.
Byron, J., Jane Zochling, Janet Roddy, et al.. (2011). MORTALITY AND CAUSES OF DEATH IN AN AUSTRALIAN SYSTEMIC SCLEROSIS COHORT. Internal Medicine Journal. 41. 12–12. 1 indexed citations
18.
Stevens, Wendy, Mandana Nikpour, Julie K. Byron, et al.. (2011). FREQUENCY, CLINICAL CHARACTERISTICS AND RISK FACTORS FOR DIGITAL ULCERS IN SYSTEMIC SCLEROSIS. Internal Medicine Journal. 41. 13–13. 3 indexed citations
19.
Nikpour, Mandana, Pravin Hissaria, J. Byron, et al.. (2011). Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort. Arthritis Research & Therapy. 13(6). R211–R211. 120 indexed citations
20.
Strange, Geoff, Leland W.K. Chung, B. Dalton, et al.. (2008). Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis. Internal Medicine Journal. 39(10). 682–691. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nascimento Costa Breakdown of academic impact, for papers by Senji Kasahara Breakdown of academic impact, for papers by Alessandro Tomelleri Breakdown of academic impact, for papers by Anand Devaraj Breakdown of academic impact, for papers by Roland du Bois Breakdown of academic impact, for papers by Paola Confalonieri Breakdown of academic impact, for papers by Jean‐François Augusto Breakdown of academic impact, for papers by Elena Ossi Breakdown of academic impact, for papers by Nuntana Kasitanon Breakdown of academic impact, for papers by Shuzo Yoshida
Rankless by CCL
2026